Notably, LNP-encapsulated siRNAs targeting high-mobility group box 1 (HMGB1)289 and methylation-controlled J protein (MCJ)290 have been tested in pre-clinical NASH models, respectively. This evidence concerns the gene DNAJC15 and metabolic dysfunction-associated steatohepatitis.